Biomerica, Inc. Share Price & Technical Analysis
BMRA · $2.49 (+2.05%)
Healthcare / Medical Devices
$2.49
+2.05%
Biomerica, Inc., a biomedical technology company, engages in developing, patenting, manufacturing, and marketing diagnostic and therapeutic products for the detection and treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, nasal or fecal specimens from patients in the diagnosis of various diseases, food intolerances, and othe…
Price chart
Seasonality
May has 3 positive and 2 negative years (last 5 years shown)
14% return in May, -3% avg return in past 3 year May month.
7% return in 2026, -42% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | -4% | -12% | 5% | 5% | 14% | – | – | – | – | – | – | – | 7% |
| 25 | 60% | 45% | -23% | -20% | -17% | 3% | 3% | -3% | -7% | 0% | -14% | 9% | 36% |
| 24 | -24% | 32% | -33% | -32% | 2% | -24% | -24% | 35% | -26% | 15% | 3% | -17% | -92% |
| 23 | -14% | -6% | -30% | -28% | 6% | 3% | -2% | -2% | -34% | 5% | -3% | 35% | -69% |
| 22 | 7% | 3% | 5% | -10% | -10% | -17% | -4% | 29% | 14% | -17% | 5% | -3% | 1% |
Monthly return % by calendar month · historical pattern, not a forecast
Weak · Downtrend · Strong
Biomerica, Inc., a biomedical technology company, engages in developing, patenting, manufacturing, and marketing diagnostic and therapeutic products for the detection and treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, nasal or fecal specimens from patients in the diagnosis of various diseases, food intolerances, and other medical complications, as well as to measure the levels of specific bacteria, hormones, antibodies, antigens, and other substances which may exist in the human body, stools, or blood in extremely small concentrations. It sells its products for treating gastrointestinal diseases and food intolerances, as well as various esoteric tests at the physicians' offices and over-the-counter drugstores, and hospital/clinical laboratories. The company is also involved in the development of InFoods IBS, that uses a simple blood sample to identify patient-specific foods which may alleviate irritable bowel syndrome symptoms; and hp+detect, a H. Pylori diagnostic test that indicates if a patient is infected with the Helicobacter pylori bacteria. The company has strategic partnerships with Phoenix Airmid Biomedical and CanAlt Health Labs for launching the inFoods platform in Canada. Biomerica, Inc. was incorporated in 1971 and is headquartered in Irvine, California.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$6.80M
P/E ratio
—
52W high
$4.60
52W low
$1.87
Volume
8,414
Beta
0.28
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is Biomerica, Inc. share price today?
- Biomerica, Inc. (BMRA) last traded around $2.49 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does BMRA have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for BMRA. Download the app for real-time alerts.
- How can I analyze Biomerica, Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.